102 related articles for article (PubMed ID: 6837522)
1. Demonstration of bacteroides capsules by light microscopy and ultrastructural cytochemistry.
Strohm H; Payne CM; Ryan KJ
Am J Clin Pathol; 1983 May; 79(5):591-7. PubMed ID: 6837522
[TBL] [Abstract][Full Text] [Related]
2. Encapsulated strains of Bacteroides fragilis in clinical specimens.
Lindberg AA; Berthold P; Nord CE; Weintraub A
Med Microbiol Immunol; 1979 Mar; 167(1):29-36. PubMed ID: 440201
[TBL] [Abstract][Full Text] [Related]
3. Isolation and identification of encapsulated strains of Bacteroides fragilis.
Kasper DL; Hayes ME; Reinap BG; Craft FO; Onderdonk AB; Polk BF
J Infect Dis; 1977 Jul; 136(1):75-81. PubMed ID: 328787
[TBL] [Abstract][Full Text] [Related]
4. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
Kasper DL
J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a direct fluorescent antibody staining method for rapid identification of members of the bacteroides fragilis group.
DeGirolami PC; Mepani CP
Am J Clin Pathol; 1981 Jul; 76(1):78-82. PubMed ID: 7020409
[TBL] [Abstract][Full Text] [Related]
6. Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis.
Kasper DL; Lindberg AA; Weintraub A; Onderdonk AB; Lönngren J
Rev Infect Dis; 1984; 6 Suppl 1():S25-9. PubMed ID: 6718939
[TBL] [Abstract][Full Text] [Related]
7. Pathogenicity of the Bacteroides fragilis group.
Brook I
Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
[TBL] [Abstract][Full Text] [Related]
8. Use of polymerase chain reaction fingerprinting to compare clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron from Germany and the United States.
Claros MC; Hunt Gerardo S; Citron DM; Goldstein EJ; Schönian G; Rodloff AC
Clin Infect Dis; 1997 Sep; 25 Suppl 2():S295-8. PubMed ID: 9310712
[TBL] [Abstract][Full Text] [Related]
9. Surface structures, haemagglutination and cell surface hydrophobicity of Bacteroides fragilis strains.
Oyston PC; Handley PS
J Gen Microbiol; 1990 May; 136(5):941-8. PubMed ID: 1696307
[TBL] [Abstract][Full Text] [Related]
10. [Selected properties of Bacteroides fragilis enterotoxigenic strains].
Rokosz A; Meisel-Mikołajczyk F
Med Dosw Mikrobiol; 1995; 47(3-4):183-8. PubMed ID: 8833930
[TBL] [Abstract][Full Text] [Related]
11. [Bacteroides and appendicitis (author's transl)].
Werner H; Kunstek-Santos H; Schockemöhle C; Gündürewa M
Pathol Microbiol (Basel); 1975; 42(2):110-8. PubMed ID: 1178229
[TBL] [Abstract][Full Text] [Related]
12. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
Kasper DL; Onderdonk AB
Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
[TBL] [Abstract][Full Text] [Related]
13. An electron microscopic study of surface polysaccharides in Bacteroides.
Dahlén G; Nygren H
Microbios; 1982; 35(140):119-29. PubMed ID: 6186892
[TBL] [Abstract][Full Text] [Related]
14. Separation of capsulate and non-capsulate Bacteroides fragilis on a discontinuous density gradient.
Patrick S; Reid JH
J Med Microbiol; 1983 May; 16(2):239-41. PubMed ID: 6842574
[No Abstract] [Full Text] [Related]
15. Adherence of Bacteroides fragilis in vivo.
Onderdonk AB; Moon NE; Kasper DL; Bartlett JG
Infect Immun; 1978 Mar; 19(3):1083-7. PubMed ID: 640723
[TBL] [Abstract][Full Text] [Related]
16. Quantitative variability in requirements for opsonization of strains within the Bacteroides fragilis group.
Bjornson AB; Bjornson HS; Ashraf M; Lang TJ
J Infect Dis; 1983 Oct; 148(4):667-75. PubMed ID: 6631060
[TBL] [Abstract][Full Text] [Related]
17. The growth and survival of capsulate and non-capsulate Bacteroides fragilis in vivo and in vitro.
Patrick S; Reid JH; Larkin MJ
J Med Microbiol; 1984 Jun; 17(3):237-46. PubMed ID: 6726783
[TBL] [Abstract][Full Text] [Related]
18. Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization.
Kasper DL; Weintraub A; Lindberg AA; Lönngren J
J Bacteriol; 1983 Feb; 153(2):991-7. PubMed ID: 6185469
[TBL] [Abstract][Full Text] [Related]
19. gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.
Oh H; El Amin N; Davies T; Appelbaum PC; Edlund C
Antimicrob Agents Chemother; 2001 Jul; 45(7):1977-81. PubMed ID: 11408211
[TBL] [Abstract][Full Text] [Related]
20. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
Onderdonk AB; Kasper DL; Cisneros RL; Bartlett JG
J Infect Dis; 1977 Jul; 136(1):82-9. PubMed ID: 886206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
